213
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Awareness and Correlates of HIV Pre-Exposure Prophylaxis (PrEP) Among HIV-negative People Who Access Syringe Services in Seattle, Washington

ORCID Icon, , , &

References

  • Allen, S. T., O’Rourke, A., White, R. H., Smith, K. C., Weir, B., Lucas, G. M., Sherman, S. G., & Grieb, S. M. (2020). Barriers and facilitators to PrEP use among people who inject drugs in rural Appalachia: A qualitative study. AIDS and Behavior, 24(6), 1942–1950. https://doi.org/10.1007/s10461-019-02767-3
  • Bazzi, A. R., Biancarelli, D. L., Childs, E., Drainoni, M.-L., Edeza, A., Salhaney, P., Mimiaga, M. J., & Biello, K. B. (2018). Limited knowledge and mixed interest in pre-exposure prophylaxis for HIV prevention among people who inject drugs. AIDS Patient Care and STDs, 32(12), 529–537. https://doi.org/10.1089/apc.2018.0126
  • Biello, K. B., Bazzi, A. R., Mimiaga, M. J., Biancarelli, D. L., Edeza, A., Salhaney, P., Childs, E., & Drainoni, M. L. (2018). Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduction Journal, 15(1), 55 https://doi.org/10.1186/s12954-018-0263-5
  • Biello, K. B., Mimiaga, M. J., Valente, P. K., Saxena, N., & Bazzi, A. R. (2021). The past, present, and future of PrEP implementation among people who use drugs. Current HIV/AIDS Reports, 18(4), 328–338. https://doi.org/10.1007/s11904-021-00556-z
  • Burt, R. D., Tinsley, J., & Glick, S. N. (2017). A decline in HIV testing among persons who inject drugs in the Seattle area, 2004–2015. Journal of Acquired Immune Deficiency Syndromes (1999), 75(Suppl 3), S346–S351. https://doi.org/10.1097/QAI.0000000000001409
  • Carter, G., Meyerson, B., Rivers, P., Crosby, R., Lawrence, C., Cope, S. D., DeBruicker, D., Levin, S., Meeks, W., Thomas, C., Turner, B., Abert, C., Coles, H., Allen, A., Gonzalez-Fagoaga, E., & Grivois-Shah, R. (2021). Living at the confluence of stigmas: PrEP Awareness and feasibility among people who inject drugs in two predominantly rural states. AIDS and Behavior, 25(10), 3085–3096. https://doi.org/10.1007/s10461-021-03304-x
  • Centers for Disease Control and Prevention: US Public Health Service. (2018). Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: A clinical practice guideline. Retrieved October 4, 2019 from https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf
  • Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., Chuachoowong, R., Gvetadze, R. J., McNicholl, J. M., Paxton, L. A., Curlin, M. E., Hendrix, C. W., & Vanichseni, S. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet (London, England), 381(9883), 2083–2090. https://doi.org/10.1016/S0140-6736(13)61127-7
  • Des Jarlais, D. C., Sypsa, V., Feelemyer, J., Abagiu, A. O., Arendt, V., Broz, D., Chemtob, D., Seguin-Devaux, C., Duwve, J. M., Fitzgerald, M., Goldberg, D. J., Hatzakis, A., Jipa, R. E., Katchman, E., Keenan, E., Khan, I., Konrad, S., McAuley, A., Skinner, S., & Wiessing, L. (2020). HIV outbreaks among people who inject drugs in Europe, North America, and Israel. The Lancet HIV, 7(6), e434–e442. https://doi.org/10.1016/S2352-3018(20)30082-5
  • Des Jarlais, D., Sypsa, V., Freelemyer, J., Abagiu, A., Arendt, V., & Devaux, C. (2018). Complacency is the new problem: Comparative analysis of recent outbreaks of HIV among persons who inject drugs in Europe and North America. In International AIDS Conference, Amsterdam, Netherlands. http://natap.org/2018/IAC/IAS2018GlobalOutbreaksPosterFinalopy.pdf
  • Footer, K. H. A., Lim, S., Rael, C. T., Greene, G. J., Carballa-Diéguez, A., Giguere, R., Martinez, M., Bockting, W., D’Aquila, R., & Sherman, S. G. (2019). Exploring new and existing PrEP modalities among female sex workers and women who inject drugs in a U.S. city. AIDS Care, 31(10), 1207–1213. https://doi.org/10.1080/09540121.2019.1587352
  • Glick, S. N., Burt, R., Kummer, K., Tinsley, J., Banta-Green, C. J., & Golden, M. R. (2018). Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington. Drug and Alcohol Dependence, 182, 86–92. https://doi.org/10.1016/j.drugalcdep.2017.10.011
  • Golden, M. R., Lechtenberg, R., Glick, S. N., Dombrowski, J., Duchin, J., Reuer, J. R., Dhanireddy, S., Neme, S., & Buskin, S. E. (2019). Outbreak of human immunodeficiency virus infection among heterosexual persons who are living homeless and inject drugs - Seattle, Washington, 2018. MMWR. Morbidity and Mortality Weekly Report, 68(15), 344–349. https://doi.org/10.15585/mmwr.mm6815a2
  • Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernandez, M., O’Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., & Duda, S. N. (2019). The REDCap consortium: Building an international community of software platform partners. Journal of Biomedical Informatics, 95, 103208 https://doi.org/10.1016/j.jbi.2019.103208
  • Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381. https://doi.org/10.1016/j.jbi.2008.08.010
  • HIV/AIDS Epidemiology Report for King County and Washington State. (2018). Public Health Seattle and King County HIV/AIDS Epidemiology Unit & Washington State Department of Health Infectious Disease Assessment Unit. www.kingcounty.gov/hivepi
  • Jenkins, L. M., Banta-Green, C. J., Maynard, C., Kingston, S., Hanrahan, M., Merrill, J. O., & Coffin, P. O. (2011). Risk factors for nonfatal overdose at Seattle-area syringe exchanges. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 88(1), 118–128. https://doi.org/10.1007/s11524-010-9525-6
  • Jo, Y., Bartholomew, T. S., Doblecki-Lewis, S., Rodriguez, A., Forrest, D. W., Tomita-Barber, J., Oves, J., & Tookes, H. E. (2020). Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida. PLoS One, 15(4), e0231424 https://doi.org/10.1371/journal.pone.0231424
  • Kuo, I., Olsen, H., Patrick, R., Phillips, G., Magnus, M., Opoku, J., Rawls, A., Peterson, J., Hamilton, F., Kharfen, M., & Greenberg, A. (2016). Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC. Drug and Alcohol Dependence, 164, 8–13. https://doi.org/10.1016/j.drugalcdep.2016.02.044
  • McFarland, W., Lin, J., Santos, G. M., Arayasirikul, S., Raymond, H. F., & Wilson, E. (2020). Low PrEP awareness and use among people who inject drugs, San Francisco, 2018. AIDS and Behavior, 24(5), 1290–1293. https://doi.org/10.1007/s10461-019-02682-7
  • Peavy, K. M., Banta-Green, C. J., Kingston, S., Hanrahan, M., Merrill, J. O., & Coffin, P. O. (2012). "Hooked on" prescription-type opiates prior to using heroin: Results from a survey of syringe exchange clients. Journal of Psychoactive Drugs, 44(3), 259–265. https://doi.org/10.1080/02791072.2012.704591
  • Peters, P. J., Pontones, P., Hoover, K. W., Patel, M. R., Galang, R. R., Shields, J., Blosser, S. J., Spiller, M. W., Combs, B., Switzer, W. M., Conrad, C., Gentry, J., Khudyakov, Y., Waterhouse, D., Owen, S. M., Chapman, E., Roseberry, J. C., McCants, V., Weidle, P. J., … Duwve, J. M. (2016). HIV infection linked to injection use of oxymorphone in Indiana, 2014-2015. New England Journal of Medicine, 375(3), 229–239. https://doi.org/10.1056/NEJMoa1515195
  • Roth, A. M., Aumaier, B. L., Felsher, M. A., Welles, S. L., Martinez-Donate, A. P., Chavis, M., & Van Der Pol, B. (2018). An exploration of factors impacting preexposure prophylaxis eligibility and access among syringe exchange users. Sexually Transmitted Diseases, 45(4), 217–221. https://doi.org/10.1097/OLQ.0000000000000728
  • Roth, A., Tran, N., Piecara, B., Welles, S., Shinefeld, J., & Brady, K. (2019). Factors associated with awareness of pre-exposure prophylaxis for HIV among persons who inject drugs in Philadelphia: National HIV behavioral surveillance, 2015. AIDS and Behavior, 23(7), 1833–1840. https://doi.org/10.1007/s10461-018-2293-0
  • Schneider, K. E., White, R. H., Musci, R. J., O’Rourke, A., Kilkenny, M. E., Sherman, S. G., & Allen, S. T. (2020). The relationship between polysubstance injection drug use, HIV risk behaviors, and interest in pre-exposure prophylaxis (PrEP) among people who inject drugs in rural West Virginia. Journal of Studies on Alcohol and Drugs, 81(6), 740–749. https://doi.org/10.15288/jsad.2020.81.740
  • Sherman, S. G., Schneider, K. E., Park, J. N., Allen, S. T., Hunt, D., Chaulk, C. P., & Weir, B. W. (2019). PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland. Drug and Alcohol Dependence, 195, 148–155. https://doi.org/10.1016/j.drugalcdep.2018.08.014
  • Smith, M., Elliott, L., Hutchinson, S. J., Metcalfe, R., Flowers, P., & McAuley, A. (2021). Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an hiv outbreak: A qualitative study. The International Journal on Drug Policy, 88, 103033 https://doi.org/10.1016/j.drugpo.2020.103033
  • Walters, S. M., Reilly, K. H., Neaigus, A., & Braunstein, S. (2017a). Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: The importance of networks and syringe exchange programs for HIV prevention. Harm Reduction Journal, 14(1). https://doi.org/10.1186/s12954-017-0166-x
  • Walters, S. M., Rivera, A. V., Starbuck, L., Reilly, K. H., Boldon, N., Anderson, B. J., & Braunstein, S. (2017b). Differences in awareness of pre-exposure prophylaxis and post-exposure prophylaxis among groups at-risk for HIV in New York State: New York City and Long Island, NY, 2011-2013. JAIDS Journal of Acquired Immune Deficiency Syndromes, 75, S383–S391. https://doi.org/10.1097/QAI.0000000000001415

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.